Long-term immunogenicity of BNT162b2 vaccination in older people and younger health-care workers-Reference-Cited by-同舟云学术

Long-term immunogenicity of BNT162b2 vaccination in older people and younger health-care workers

Published:2021-11 Issue:11 Volume:9 Page:e104-e105
ISSN:2213-2600
Container-title:The Lancet Respiratory Medicine
language:en
Short-container-title:The Lancet Respiratory Medicine

Author:

Tober-Lau Pinkus,Schwarz Tatjana,Vanshylla Kanika,Hillus David,Gruell Henning,Suttorp Norbert,Landgraf Irmgard,Kappert Kai,Seybold Joachim,Drosten Christian,Klein Florian,Kurth Florian,Sander Leif Erik,Corman Victor Max

Funder

German Research Foundation

Federal Ministry of Education and Research Berlin Office

Publisher

Elsevier BV

Subject

Pulmonary and Respiratory Medicine

Reference8 articles.

1. BNT162b2 mRNA Covid-19 vaccine in a nationwide mass vaccination setting;Dagan;N Engl J Med,2021

2. Six month safety and efficacy of the BNT162b2 mRNA COVID-19 vaccine;Thomas;medRxiv,2021

3. Spike-antibody waning after second dose of BNT162b2 or ChAdOx1;Shrotri;Lancet,2021

4. Delayed antibody and T-cell response to BNT162b2 vaccination in the elderly, Germany;Schwarz;Emerg Infect Dis,2021

5. Correlation of SARS-CoV-2 breakthrough infections to time-from-vaccine; preliminary study;Mizrahi;medRxiv,2021

Cited by 61 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Kinetics of pro- and anti-inflammatory spike-specific cellular immune responses in long-term care facility residents after COVID-19 mRNA primary and booster vaccination: a prospective longitudinal study in Japan;Immunity & Ageing;2024-06-22

2. Functional antibody responses targeting the Spike protein of SARS-CoV-2 Omicron XBB.1.5 in elderly nursing home residents following Wuhan-Hu-1-based mRNA booster vaccination;Scientific Reports;2024-05-24

3. Kinetics of pro- and anti-inflammatory spike-specific T-cell responses in long-term care facility residents after COVID-19 mRNA primary and booster vaccination: A prospective longitudinal study in Japan;2024-04-29

4. Anti‐spike protein IgG antibody responses up to 3 months after the third dose of the BNT162b2 mRNA vaccine in medical care workers;Journal of General and Family Medicine;2024-03-26

5. Immunogenicity assessment of elder hepatocellular carcinoma patients after inactivated whole-virion SARS-CoV-2 vaccination;Expert Review of Vaccines;2023-11-10